High Court Won't Hear $2.7M Fees Appeal In BioScrip Deal
The U.S. Supreme Court on Tuesday declined to pick up an appeal challenging a $2.7 million attorney fee award included as part of a settlement between shareholders and specialty pharmacy BioScrip...To view the full article, register now.
Already a subscriber? Click here to view full article